BioSpace News Archive

Biovaxys Closes First Tranche of Non-Brokered Private Placement

BioVaxys Technology Corp. is pleased to announce that it has closed the first tranche of its previously announced non-brokered private placement.

August 26, 2022
·
5 min read
Lone Star Bio

Nanoscope Therapeutics to Present at the Retina Forum 2022

Nanoscope Therapeutics Inc. today announced that Aaron Osborne , Chief Medical Officer, will give a presentation on clinical development of Nanoscope’s Multi-Characteristic Opsin (MCO) gene therapy platform.

August 26, 2022
·
1 min read
Genetown

Inhibikase Therapeutics Announces FDA Clearance of Investigational New Drug Application for IkT-001Pro for the Treatment of Chronic Myelogenous Leukemia

Inhibikase Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has reviewed its Investigational New Drug (IND) application for IkT-001Pro for the treatment of Chronic Myelogenous Leukemia (CML) and issued a Study May Procced (SMP) letter.

August 26, 2022
·
6 min read
Biotech Bay

Biomea Fusion Presents Additional Preclinical Data Demonstrating Anti-Tumor Activity and Mechanistic Evidence for BMF-219 in Diffuse Large B-Cell Lymphoma and Multiple Myeloma Models at International Myeloma Society Annual Meeting

Biomea Fusion, Inc. announced today the presentation of two posters at the 19th International Myeloma Society (IMS) Annual Meeting, which took place August 25-27, 2022 in Los Angeles, California.

August 26, 2022
·
9 min read
RAIsonance Releases Preliminary Results from AudibleHealth Dx Validation Study

RAIsonance, Inc., a group of AI-powered technology solutions companies, today reported the preliminary results of its AudibleHealth Dx clinical validation study.

August 26, 2022
·
7 min read
Business

Aziyo Biologics Appoints Michelle LeRoux Williams, Ph.D as Chief Scientific OfficerRenown Pioneer in Regenerative Medicine to Lead Company’s Pipeline Development Initiatives

Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company announced today that Michelle LeRoux Williams, Ph.D. has been appointed Chief Scientific Officer.

August 26, 2022
·
3 min read
BioCapital

Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Conditional Marketing Authorization in the United Kingdom for Use in Adolescents Aged 12 Through 17

Novavax, Inc. (Nasdaq: NVAX), today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom (UK) has granted expanded conditional marketing authorization (CMA) for Nuvaxovid™ (NVX-CoV2373) COVID-19 vaccine.

August 26, 2022
·
12 min read
FDA

Incyte Announces FDA Approval of Pemazyre® (pemigatinib) as the First and Only Targeted Treatment for Myeloid/Lymphoid Neoplasms (MLNs) with FGFR1 Rearrangement

Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Pemazyre® (pemigatinib), a selective fibroblast growth factor receptor (FGFR) inhibitor, for the treatment of adults with relapsed or refractory myeloid/lymphoid neoplasms (MLNs) with FGFR1 rearrangement.

August 26, 2022
·
16 min read
Surge In Launch Of Low-Cost Balloon Catheters Are Expected To Offer Lucrative Revenue Opportunities For Key Players In Normal Balloon Catheter Market

By Material Type, Nylon Normal Balloon Catheters Are Expected To Occupy Dominant Revenue Share Of 50% In The Market

August 26, 2022
·
5 min read
Bioprocess Technology Market Competitive Research and Precise Outlook 2021 to 2031

Wilmington, Delaware, United States, Transparency Market Research Inc. – According to the report, the global bioprocess technology market was valued at US$ 22.4 Mn in 2020 and is projected to expand at a CAGR of 8.3% from 2021 to 2031.

August 26, 2022
·
6 min read